Table 7: Factors associated with ART modification
Variable | Modified | Not modified | OR (95% CI) | P value |
Gender Male Female |
60 (33.9) 117 (66.1) |
111 (36.5) 193 (63.5) |
0.9 (0.6-1.3) 1.0 |
0.563 |
Age | 36.9 (9.0) | 37.1 (9.9 | - | 0.786 |
Initial WHO stage I II III IV |
30 (16.9) 50 (28.2) 65 (36.7) 32 (18.1) |
109 (35.9) 92 (30.3) 82 (27.0) 21 (6.9) |
1.0 2.0 (1.2-3.4) 2.9 (1.7-4.8) 5.5 (2.8-11.0) |
0.012 < 0.001 < 0.001 |
CD4+ at initiation of therapy | 120 (50-206) | 220 (117-314) | - | < 0.001 |
Initial CD4 cell counts < 100 100-200 >200 |
79 (44.6) 51 (28.8) 47 (26.6) |
63 (20.7) 74 (24.3) 167 (54.9) |
4.5 (2.8-7.1) 2.4 (1.5-4.0) 1.0 |
< 0.001 < 0.001 |
Duration of initial regimen | 26 (15-38) | 16 (11-28) | - | < 0.001 |